+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Matrix-degrading metalloproteinases in tumor progression



Matrix-degrading metalloproteinases in tumor progression



Princess Takamatsu Symposia 24: 152-161



The matrix-degrading metalloproteinases (MMPs) have been implicated in tumor invasion and metastasis. Recently it has become clear that the expression of MMPs in tumors is frequently localized to stromal cells surrounding malignant tumor cells. In the mouse skin model of multi-stage carcinogenesis, the MMP stromelysin is expressed in stromal fibroblast-like cells surrounding benign and malignant squamous cell carcinomas. Conversion of these tumors to highly invasive and metastatic spindle-cell tumors is however, associated with the expression of stromelysin-1 mRNA in the tumor cells themselves. The analysis of MMPs in human colon adenocarcinomas at different stages of tumor progression revealed that matrilysin was the only MMP expressed in the tumor cells, while stromelysin-1 and stromelysin-3 mRNA was detected in stromal cells surrounding malignant tumor cells. Matrilysin mRNA is detected in benign tumors as well as malignant tumor cells, and the relative level and percent of tumors expressing matrilysin correlates with the stage of tumor progression. These results suggest that both stromal and tumor cell metalloproteinases may contribute to tumor invasion and metastasis, and also suggests that MMPs may play a role in earlier events in the tumor progression pathway. A potential role for MMPs in tumor growth is illustrated by results which suggest that the expression of matrilysin in human colon cancer-derived cells increases tumorigenicity following injection into the cecum, and that transgenic mice expressing matrilysin mRNA show a marked proliferative response. MMPs may therefore play multiple roles in tumor progression.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046631539

Download citation: RISBibTeXText

PMID: 8983072


Related references

The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis. Turkish Journal of Gastroenterology 20(1): 41-47, 2009

Functions of the extracellular matrix and matrix degrading proteases during tumor progression. Brazilian Journal of Medical and Biological Research 32(7): 805-812, 1999

Matrix metalloproteinases in tumor progression. Proceedings of the American Association for Cancer Research Annual Meeting 40: 769-770, March, 1999

Matrix metalloproteinases and tumor progression. Advances in Experimental Medicine and Biology 532: 91-107, 2003

Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Reviews 14(4): 351-362, 1995

Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion & Metastasis 14(1-6): 234-245, 1994

Regulation of tumor progression of EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases. FASEB Journal 14(4): A540, March 15, 2000

Matrix metalloproteinases and their inhibitors in tumor progression. Annals of the New York Academy of Sciences 732: 222-232, 1994

The role of matrix metalloproteinases in intestinal tumor progression. Clinical & Experimental Metastasis 14(SUPPL 1): 59-60, 1996

Complex roles of matrix metalloproteinases in tumor progression. Current Topics in Microbiology and Immunology 213: 1-21, 1996

Matrix metalloproteinases: Multifunctional contributors to tumor progression. Molecular Medicine Today 6(4): 149-156, April, 2000

Matrix metalloproteinases: promoters of tumor progression and invasiveness. Israel Medical Association Journal 4(4): 280-282, 2002

Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87(3-4): 329-342, 2005

Matrix metalloproteinases and inhibitors Changing roles in tumor progression. FASEB Journal 15(5): A744, March 8, 2001